
ARRY · NASDAQ-GM
A current consensus rating cannot be established from the supplied evidence, although Benzinga reports ratings from 26 analysts. Published targets are widely dispersed: Benzinga cites a $9.68 consensus, with a $5 low and $15 high, while Fintel reports a $6.06-to-$15.75 range and a $10.18 average. Guggenheim is the most bullish named analyst in the evidence at $15, while Roth MKM is tied to the $5 low; UBS also reduced its target to $5. The clear direction of the latest revision is negative, with UBS moving from Buy to Neutral and cutting its target from $10 to $5. The substantive disagreement is whether expanding solar and power demand can overcome weak cash flow and continuing losses.